Clinical and immunological characterization of patients with systemic sclerosis overlapping primary biliary cirrhosis: A comparison with patients with systemic sclerosis alone

Journal of Dermatology

Volumn 26, Issue 1, 1999, Pages 18-22

  Akimoto, Sachiko ^a   Ishikawa, Osamu ^b   Muro, Yoshinao ^b   Takagi, Hitoshi ^b   Tamura, Taeko ^b   Miyachi, Yoshiki ^b  

^a GUNMA UNIVERSITY   (Japan)

^b NONE

Author keywords

Anticentromere antibody (ACA); CREST syndrome; Limited cutaneous systemic sclerosis (lSSc); Primary biliary cirrhosis

Indexed keywords

ANTIBODY; CENTROMERE ANTIBODY; PROTEIN C; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CALCINOSIS; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; IMMUNOREACTIVITY; INCIDENCE; ONSET AGE; PRIMARY BILIARY CIRRHOSIS; SERODIAGNOSIS; SJOEGREN SYNDROME; SYNDROME CREST; SYSTEMIC SCLEROSIS; TELANGIECTASIA;

EID: 0033024220     PISSN: 03852407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1346-8138.1999.tb03503.x     Document Type: Article

References (17)

1. Rodnan GP: Progressive systemic sclerosis (scleroderma), in McCarty DJ (ed): Arthritis and Allied Conditions, 9th ed, Lea Åï Febiger, Philadelphia, 1979, pp 762-809.
2. Kaplan MM: Primary biliary cirrhosis, N Engl J Med, 316: 521-528, 1987.
3. Clarke AK, Galbraith RM, Hamilton EBD, Williams R: Rheumatic disorders in primary biliary cirrhosis, Ann Rheum Dis, 37: 42-47, 1978.
4. Powell FC, Schroeter AL, Dickson ER: Primary biliary cirrhosis and the CREST syndrome: A report of 22 cases, Quart J Med, 62: 75-82, 1987.
5. Tan EM, Rodnan GP, Garcia I, Moroi Y, Fritzler MJ, Peebles C: Diversity of antinuclear antibodies in progressive systemic sclerosis: Anticentromere antibody and its relationship to CREST syndrome, Arthritis Rheum, 23: 617-625, 1980.
6. Makinen D, Fritzler M, Davis P, Sherlock S: Anticentromere antibodies in primary biliary cirrhosis, Arthritis Rheum, 26: 914-917, 1983.
7. Earnshaw W, Bordwell B, Marino C, Rothfield N: Three human chromosomal autoantigens are recognized by sera from patients with anti-centromere antibodies, J Clin Invest, 77: 426-430, 1986.
8. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee: Preliminary criteria for the classification of systemic sclerosis (scleroderma), Arthritis Rheum, 23: 581-590, 1980.
9. LeRoy EC, Kreig T, Black C, et al: Scleroderma (systemic sclerosis): Classification, subsets, and pathogenesis, J Rheumatol, 15: 202-205, 1988.
10. Sasaki H, Inoue K, Higuchi K, et al: Primary biliary cirrhosis in Japan: National survey by the subcomittee on autoimmune hepatitis, Gastroenterologia Japonica, 20: 476-485, 1985.
11. Sjögren's Syndrome Research Committee Japan: Diagnostic Criteria for Sjögren Syndrome: Annual Report of the Ministry of Health and Welfare Japan, p 6, 1977.
12. Masumoto H, Sugimoto K, Okazaki T: Alophoid satellite DNA is tightly associated with centromere antigens in human chromosomes throughout the cell cycle, Exp Cell Res, 181: 181-196, 1989.
13. Muro Y, Sugimoto K, Okazaki T, Ohashi M: The heterogeneity of anticentromere antibodies in immunoblotting analysis, J Rheumatol, 17: 1042-1047, 1990.
14. Rodnan GP, Jablonska S, Medsger TA Jr: Classification and nomenclature of progressive systemic sclerosis (Scleroderma). Clin Rheum Dis, 5: 5-13, 1979.
15. Winterbauer RH: Multiple telangiectasia, Raynaud's phenomenon, sclerodactyly, and subcutaneous calcinosis: A syndrome mimicking hereditary hemorrhagic telangiectasia, Johns Hopkins Hosp Bull, 114: 361-383, 1964.
16. McHugh NJ, James IE, Fairburn K, Maddison PJ: Autoantibodies to mitochondrial and centromere antigens in primary biliary cirrhosis and systemic sclerosis, Clin Exp Immunol, 81: 244-249, 1990.
17. Alarcón-Segovia D, Díaz-Jouanen E, Fishbein E: Feature of Sjögren syndrome in primary biliary cirrhosis, Ann Intern Med, 79: 31-36, 1973.